Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aclarion Inc ACON

Healthcare Biotechnology
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ACON)

Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants

TheNewsWire 4 days ago

Aclarion Announces Pricing of $14.4 Million Public Offering of Common Stock and Warrants

TheNewsWire 7 days ago

Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market

TheNewsWire January 3, 2025

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

GlobeNewswire November 21, 2024

Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st

Accesswire November 14, 2024

Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit

GlobeNewswire October 10, 2024

Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes

GlobeNewswire September 27, 2024

Aclarion Provides Corporate Update on Nociscan AI Technology Milestones

GlobeNewswire September 12, 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

Accesswire September 11, 2024
View More News ››

Opinion & Analysis (NDAQ:ACON)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ACON)

Aclarion Provides Corporate Update on Nociscan AI Technology

JUST IN: $ACON Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesSuccessful milestones achieved and upcoming...
whytestocks - September 12, 2024

Aclarion Added to PRISM Emerging Medical Devices Index

News; $ACON Aclarion Added to PRISM Emerging Medical Devices IndexCompany's industry-first technology addresses chronic low back...
whytestocks - September 6, 2024

Aclarion, Inc. (NASDAQ:ACON) &#8211; A Promising Medtech Inn

http://beyondspx.com/2024/08/02/aclarion-inc-nasdaqacon-a-promising-medtech-innovator-navigating-challenges/
MikeTester - August 3, 2024

Aclarion Expands Commercial Engagement With The London Clini

Breaking News: $ACON Aclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater...
whytestocks - June 25, 2024

US Stocks Edge Higher; Domino's Posts Upbeat Earnings | Benz

JUST IN: $ACON US Stocks Edge Higher; Domino's Posts Upbeat Earnings | BenzingaU.S. stocks traded mostly higher this morning, with...
whytestocks - February 26, 2024

Aclarion Announces Pricing of $3.0 Million Public Offering

NEWS: $ACON Aclarion Announces Pricing of $3.0 Million Public OfferingBROOMFIELD, CO - ( NewMediaWire ) - February 26, 2024 - Aclarion...
whytestocks - February 26, 2024
View more Bullboard ››

Biosenta Inc.

Biosenta Inc.

Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and ...
View More »